FINWIRES · TerminalLIVE
FINWIRES

加拿大帝國商業銀行(CIBC)將Keyera和Pembina列為第一季財報季前最值得關注的能源基礎設施公司。

-- 加拿大帝國商業銀行資本市場（CIBC Capital Markets）週三將Keyera（KEY.TO）和Pembina Pipeline（PPL.TO）列為第一季財報季的首選能源基礎設施公司。 CIBC表示，Keyera在即將完成的Plains天然氣液體資產的收購中蘊藏著未實現的價值，儘管收購完成的時間更有可能在季度末。 CIBC指出，Pembina也擁有與Greenlight電力中心計畫相關的成長潛力，並且可能上調市場預期。 CIBC補充道，Pembina上調市場預期的潛力最大，儘管該公司歷來不願在年初這樣做。 CIBC表示：“更廣泛地說，我們認為持續不斷的宏觀經濟新聞可能會為那些靈活且能夠承受相應投資組合更替的投資者創造交易機會。” 加拿大帝國商業銀行（CIBC）將TC Energy（TRP.TO）的評級從“中性”上調至“跑贏大盤”，並將目標價從85.00加元上調至89.00加元，主要原因是近期項目的預期回報更高，而回報前景的改善是此次評級調整的主要驅動因素。 CIBC也將AltaGas（ALA.TO）的目標價從50.00加元上調至51.00加元，原因是其液化石油氣前景更為樂觀。 Superior Plus（SPB.TO）的評級也因其Certarus部門宣佈建設資料中心專案而從「中性」上調至「跑贏大盤」。

Price: $48.92, Change: $+0.71, Percent Change: +1.47%

Related Articles

Research

Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.

$HIG
Research

Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.

$BKR
Research

Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.

$WAB